Opqc: addressing gaps and equitably improving maternal-infant outcomes in ohio - measures of population-level perinatal outcomes indicate the state of ohio has significant disparities in…

Active Cooperative Agreement Awarded Last action

Award ID
NU58DP007264
Recipient
Awarding agency
Obligated
$2,077,600

Award facts

Completion date 81% complete
Funding agency
National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Ohio, USA

Award details come from USAspending.gov.

Description

Opqc: addressing gaps and equitably improving maternal-infant outcomes in ohio - measures of population-level perinatal outcomes indicate the state of ohio has significant disparities in maternal-infant outcomes and substantial gaps between current outcomes and optimal health. To improve perinatal health and address disparities, population-level perinatal QI initiatives, with a focus on ensuring an equitable distribution of benefits, are urgently needed. This is particularly true for ohio's women and infants affected by opioid use disorder (OUD) because throughout each wave of the opioid epidemic, ohio has been considered one of the hardest HIT states. The CDC has highlighted the significant impact of the US opioid crisis on maternal and child health and emphasized the key role of perinatal quality collaboratives in improving care and outcomes for this population. The ohio perinatal quality collaborative (opqc) will work to meaningfully improve health outcomes of pregnant women enrolled in medicaid in the state of ohio. In year 1 of the award, we will work to: (1) improve identification of pregnant medicaid enrollees with OUD, 2) link them to needed services (medical, behavioral, and social), and 3) ensure receipt of narcan during pregnancy and immediately after delivery. These objectives align with the recommendations of the ohio department of health (ODH)'s pregnancy associated mortality review report and the alliance for innovation in maternal health (aim) OUD bundle. There is strong rationale to focus on pregnant medicaid-enrolled women with OUD in ohio due to increased risk of pregnancy-associated deaths and demonstrated disparities in access to treatment, especially among black pregnant women. A key element of opqc's approach includes engagement with all key stakeholders, including patients and families. Opqc will work collaboratively with the empower project, a patient-centered collaborative of women with perinatal lived experience of OUD, to support the proposed improvement efforts. The ohio department of medicaid (ODM)'s nurture ohio online epregnancy risk assessment form (praf) system will serve as the data platform for these initial improvement efforts. The epraf system is ODM's method of pregnancy notification for medicaid enrolled women. The praf includes data on substance use screening, utilization of treatment, social determinants of health, medical risk factors, and demographics including race, ethnicity, age, and place of residence. Of the 27,842 prafs submitted between january 1, 2021 and april 30, 2022, 11,281 (40%) indicated a need for additional services or support, and 1012 (3.6%) indicated a substance use disorder (SUD). Of those identified with OUD, 42% were not in treatment. The demographics by race were 50.9% white, 40.7% black, and 6.9% hispanic, contrasting with ohio 2020 census data of 81.7% white, 13.1% black, and 4.0% hispanic. The project opqc proposes in year 1 addresses the ODH pamr recommendations, aligns with the alliance for innovation in maternal health (aim) OUD bundle, and benefits from collaboration with ODM to use praf data. Using the epraf real-time data platform will allow opqc to use practice-level and aggregate data for QI efforts, initially focusing on identifying women with OUD and increasing connection to treatment. We will use ODH vital statistics and ohio hospital association data to monitor outcomes of reducing the risk of pregnancy-associated death. Collectively, the work proposed will address the disparities in outcomes for those on medicaid and address the disparities in care and referral to treatment for pregnant black individuals. We will collaborate with patient partners, our engaged network of maternity care and infant providers, and state colleagues to implement improvement initiatives that will equitably change the outcome for mothers and babies in ohio.

Transactions

Action Obligated Date
Amendment $0
Amendment $275,000
Amendment $0
Amendment $0
Amendment $50,000
Amendment $50,000
Amendment $275,000
Amendment $275,000
Amendment $301,300
Amendment $301,300
Amendment $0
Amendment $0
Amendment $275,000
Original award $275,000
Show all 14

Subawards

Subrecipient Amount Awarded
Case Western Reserve University OPQC: Addressing gaps and equitably improving maternal-infant outcomes in Ohio $91,883
Ohiohealth Research Institute $30,755
Tel Aviv University Mechanisms of aryl hydrocarbon receptor control of eosinophilic esophagitis $50,550
The University Of Iowa OPQC: Addressing gaps and equitably improving maternal-infant outcomes in Ohio $40,874
Ohiohealth Research Institute $104,026
The University Of Iowa $79,464
The Ohio State University $173,084

Quick answers

Who received award NU58DP007264?

NU58DP007264 was awarded to Childrens Hospital Medical Center by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2022.

How much is award NU58DP007264 worth?

$2,077,600 has been obligated on NU58DP007264.

Which agency awarded NU58DP007264?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded NU58DP007264, with funding from National Center for Chronic Disease Prevention and Health Promotion (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award